(Press-News.org) (WASHINGTON, May 29, 2024) – Individuals living with sickle cell disease (SCD) who experience a delay of more than six months in transitioning from pediatric to adult care are twice as likely to be hospitalized compared to those who transition in less than two months, according to a study published in Blood Advances.
SCD is the most common inherited red blood cell disorder in the United States, affecting an estimated 100,000 people. According to the Centers for Disease Control and Prevention, SCD affects one out of every 365 Black or African American births and one out of every 16,300 Hispanic American births. Current guidelines recommend that patients with SCD transfer from pediatric care to adult care within six months.
“There are a lot of barriers to transition. Patients may not be comfortable with their new providers and not know where to go, but a lot of those challenges are addressable,” said Kristen Howell, MPH, PhD, assistant professor at Texas A&M University. “These data show that if we can decrease that transfer gap, we’ll hopefully see improved health care and outcomes.”
Researchers examined 356 young adult patients with SCD who ended pediatric care between 2012 and 2018 at St. Jude Children’s Research Hospital in Memphis and transferred to an adult SCD program at a partner institute. Approximately 88% of those studied transferred to adult health care within six months, with a median transfer time of 1.4 months. Those who transferred within six months had more outpatient pediatric and adult care visits compared to those who did not.
Young adults with transfer gaps of six months or longer were 1.89 times more likely to have had an inpatient hospital visit at two years of follow-up compared to those who transitioned in fewer than two months and had fewer outpatient visits in adult care. At eight years of follow-up, those who took more than six months to transition to adult care were 2.01 times more likely to have an inpatient visit.
“If these young adults are frequently visiting the hospital for acute reasons, it’s a pretty clear indicator that they are not doing well,” said Dr. Howell. “Having continuity of care can make a big difference, and that should be a goal for hospital systems.”
Dr. Howell noted that while barriers to transition may vary, and could include gaps in insurance coverage, gaps in how young adults understand their condition and medications, discomfort moving from a familiar facility to a new one, and potential institutional and practitioner bias. Per evidence-based guidelines, the researchers recommend beginning the process as early as age 12 and using care coordinators, or transition champions, to make the transition a smooth one.
There were a few limitations to the study, including the use of a small sample size of data from a single health care system. The researchers also excluded individuals who failed to transfer to adult care, and conclusions could not be drawn about the health care use of these patients. Further, St. Jude Children’s Research Hospital has a well-established transition program that may not be generalizable to other programs.
The researchers hope to expand their study to additional institutions to see if there are similar findings with a different population. Jane Hankins, MD, MS, director of the St. Jude Global Hematology Program, is leading efforts to evaluate St. Jude’s SCD transition program to identify which parts may be transferrable to other institutions hoping to establish or improve their own transition programs.
# # #
Additional Resources
The American Society of Hematology (ASH)’s Sickle Cell Disease Initiative aims to improve outcomes for individuals living with SCD through evidence-based research and clinical practices. ASH-led work that supports transitions from pediatric to adult care includes:
Sickle Cell Disease Centers Workshop, which trains providers on how to establish clinical centers for SCD, including supporting pediatric transitions to care;
The Sickle Cell Disease Comprehensive Care Act, legislation that will create Medicaid Health Homes to help support continuity of high-quality, comprehensive care; and
The Sickle Cell Disease Learning Community, a network of clinical sites that uses data and the input of multiple stakeholders to develop strategies that will help patients transition from pediatric to adult care.
Blood Advances (bloodadvances.org) is an online, open access journal publishing more peer-reviewed hematology research than any other academic journal worldwide. Blood Advances is part of the Blood journals portfolio (bloodjournals.org) from the American Society of Hematology (ASH) (hematology.org).
END
SAN ANTONIO — May 29, 2024 —The Supercritical Transformational Electric Power (STEP) Demo pilot plant has generated electricity for the first time using supercritical carbon dioxide (sCO2) power cycles. The $169 million, 10-megawatt sCO2 facility at Southwest Research Institute (SwRI) in San Antonio is demonstrating next-generation power production technology in a project led by GTI Energy in collaboration with SwRI, GE Vernova, the U.S. Department of Energy/National Energy Technology Laboratory (U.S. DOE/NETL), and several industry participants.
“The impact of demonstrating that the sCO2 technology works cannot be overstated,” said SwRI Project Manager Dr. Jeff ...
The Swedish capital Stockholm aims to capture more carbon dioxide than is emitted by 2030. Therefore, the city is investing in new technology at a combined heat and power plant. But it is a strategy that has been adopted without sufficient discussion of the risks, says researchers at Linköping university, Sweden.
“Stockholm has a very ambitious climate policy. But there’s also been a kind of resignation. This new technology has appeared to offer the promise of a solution. And that’s perhaps why there’s been no critical discussion at all,” says researcher Alexander Olsson at the Department of Thematic ...
In February 2023, 38 cars from a 151-car, 9,300-foot-long freight train derailed in East Palestine, Ohio, leading to the release of hazardous materials that required the evacuation of more than 2,000 residents. In recent years, such longer and heavier freight trains have become more common, primarily driven by fuel efficiency, cost-savings, and emissions reduction measures in the railroad industry.
New research in the journal Risk Analysis has confirmed that longer freight trains bring with them a higher risk of derailment. The study found that a 100-car train is more than twice as likely to experience a derailment than ...
Washington DC, May 29, 2024: In the face of growing challenges posed by unhealthy diets, all forms of malnutrition, and environmental constraints, the 2024 Global Food Policy Report (GFPR) — released today by the International Food Policy Research Institute (IFPRI) — underscores the importance of transforming complex global food systems to ensure sustainable healthy diets for all.
Progress in reducing undernutrition and micronutrient deficiencies has slowed in low- and middle-income countries, while overweight and obesity has rapidly increased worldwide. Many countries ...
Advances in electrochromic coatings may bring us closer to environmentally friendly ways to keep inside spaces cool. Like eyeglasses that darken to provide sun protection, the optical properties of these transparent films can be tuned with electricity to block out solar heat and light. Now, researchers in ACS Energy Letters report demonstrating a new electrochromic film design based on metal-organic frameworks (MOFs) that quickly and reliably switch from transparent to glare-diminishing green to thermal-insulating red.
Hongbo Xu and colleagues used MOFs in their electrochromic film because of the crystalline substances’ abilities to form thin ...
What makes chocolate taste and smell so delicious? Chemistry, of course! A variety of molecules work together to create that unmistakable aroma, but those same molecules might carry some unwanted health effects if there are too many around. According to research published in ACS’ Journal of Agricultural and Food Chemistry, while many of the compounds appeared in chocolate in low enough concentrations to be safe, higher amounts were found in some baked sweet treats.
When making chocolate, cocoa beans are roasted to help their chocolatey flavors shine. During this process, new molecules ...
New York, NY, May 29, 2024 — The New York Academy of Sciences and the Leon Levy Foundation announced today the 2024 cohort of Leon Levy Scholars in Neuroscience, continuing a program initiated by the Foundation in 2009 that has supported 170 fellows in neuroscience.
This highly regarded postdoctoral program supports exceptional young researchers across the five boroughs of New York City as they pursue innovative neuroscience research and advance their careers toward becoming independent principal investigators. Nine scholars were competitively selected for a three-year term from a broad pool of applications from more than a dozen ...
The number of refugees has sharply increased in recent decades, reaching 37.8 million in 2022. Amidst this surge, host communities—locals residing in areas where refugee camps are situated—are also positively and negatively impacted by the refugee influxes. The negative impacts include competition over scarce resources and in the unskilled labor market. While the international media and aid organizations put the spotlight on assisting refugees, the challenges faced by host communities are frequently sidelined.
In 2017, over ...
If we want cleaner air, fewer forest fires, and less severe climate change, a new UC Riverside study shows we must reduce aerosol pollution and greenhouse gases like carbon dioxide at the same time.
The study found that boreal forests in the northern hemisphere are particularly vulnerable to negative effects of cleaning up aerosol pollution. This includes forests in Canada, Alaska, northern Europe, and northern Russia.
Aerosols are small particles like dust and sea salt as well as airborne chemicals produced by fossil fuel combustion. They are responsible for poor air quality. The UCR study, published in the journal ...
A small interfering RNA (siRNA) investigational therapy that inhibits a gene involved in lipoprotein metabolism has been shown in a clinical trial led by Mount Sinai researchers to significantly reduce levels of different types of cholesterol and triglycerides in individuals with mixed hyperlipidemia, a condition in which fats build up in the blood.
In addition to seeing promising preliminary results related to safety and efficacy in clinical trials, the Mount Sinai researchers found the RNA interference (RNAi)-based therapy zodasiran to be a potentially promising option for substantially reducing a number of atherogenic lipoproteins while requiring less frequent ...
